Fondaparinux-Associated Heparin-Induced Thrombocytopenia
- 1 January 2012
- journal article
- research article
- Published by Taylor & Francis Ltd in Baylor University Medical Center Proceedings
- Vol. 25 (1), 13-15
- https://doi.org/10.1080/08998280.2012.11928771
Abstract
Heparin-induced thrombocytopenia (HIT) is an immune-mediated clinical syndrome of thrombocytopenia and thrombosis occurring after exposure to heparin. HIT most commonly occurs after exposure to unfractionated heparin but has also been reported with low-molecular-weight heparin. To date, there have been very few reports of HIT with the pentasaccharide fondaparinux, and some have proposed fondaparinux as a treatment for HIT. This article presents two cases of HIT associated with fondaparinux use.Keywords
This publication has 13 references indexed in Scilit:
- Fondaparinux and the Management of Heparin-Induced Thrombocytopenia: The Journey ContinuesAnnals of Pharmacotherapy, 2009
- A Spontaneous Prothrombotic Disorder Resembling Heparin-induced ThrombocytopeniaThe American Journal of Medicine, 2008
- Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT)Thrombosis and Haemostasis, 2008
- Heparin-Induced Thrombocytopenia Associated with FondaparinuxThe New England Journal of Medicine, 2007
- Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparinBlood, 2005
- The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort studyBlood, 2005
- Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparinBlood, 2005
- Fondaparinux or Enoxaparin for the Initial Treatment of Symptomatic Deep Venous ThrombosisAnnals of Internal Medicine, 2004
- Subcutaneous Fondaparinux versus Intravenous Unfractionated Heparin in the Initial Treatment of Pulmonary EmbolismThe New England Journal of Medicine, 2003
- Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic SurgeryA Meta-analysis of 4 Randomized Double-blind StudiesArchives of Internal Medicine, 2002